• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓灰质炎病毒神经毒性的分子基础。

The molecular basis of poliovirus neurovirulence.

作者信息

Ohka S, Nomoto A

机构信息

Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Japan.

出版信息

Dev Biol (Basel). 2001;105:51-8.

PMID:11763337
Abstract

Species specificity of poliovirus (PV) is mostly governed by host cellular molecules that serve as the PV receptor (PVR). Molecular cloning of the gene and cDNAs of human PVR and the subsequent development of PV-sensitive transgenic (Tg) mice carrying the human PVR gene made it possible to investigate molecular mechanisms for PV-specific dissemination in the whole body. After intravenous inoculation which makes artificial viremia, poliovirus appears to enter the central nervous system (CNS) at a fairly high rate via the blood brain barrier, suggesting existence of a specific permeation system for PV. This main dissemination process does not require PVR. After intramuscular inoculation, PV appears to be incorporated by endocytosis at synapses, and the endosomes containing PV transported through axons to neuron cell body, where viral replication occurs. Efficiency of viral multiplication in the CNS probably determines the neurovirulence level, which differs between PV strains. An important determinant for neurovirulence phenotype resides in the internal ribosomal entry site (IRES). This has led us to a concept of "IRES-dependent virus tropism".

摘要

脊髓灰质炎病毒(PV)的种属特异性主要由作为PV受体(PVR)的宿主细胞分子决定。人PVR基因和cDNA的分子克隆以及随后携带人PVR基因的PV敏感转基因(Tg)小鼠的培育,使得研究PV在全身特异性传播的分子机制成为可能。静脉接种造成人工病毒血症后,脊髓灰质炎病毒似乎以相当高的速率通过血脑屏障进入中枢神经系统(CNS),这表明存在PV的特定渗透系统。这个主要的传播过程不需要PVR。肌肉接种后,PV似乎通过突触处的内吞作用被摄取,含有PV的内体通过轴突运输到神经元细胞体,在那里发生病毒复制。病毒在CNS中的增殖效率可能决定神经毒力水平,不同PV毒株的神经毒力水平有所不同。神经毒力表型的一个重要决定因素存在于内部核糖体进入位点(IRES)。这使我们形成了“依赖IRES的病毒嗜性”这一概念。

相似文献

1
The molecular basis of poliovirus neurovirulence.脊髓灰质炎病毒神经毒性的分子基础。
Dev Biol (Basel). 2001;105:51-8.
2
Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.循环型脊髓灰质炎病毒独立于脊髓灰质炎病毒受体向中枢神经系统的高效递送。
Virology. 1997 Mar 17;229(2):421-8. doi: 10.1006/viro.1997.8450.
3
Retrograde transport of intact poliovirus through the axon via the fast transport system.完整脊髓灰质炎病毒通过快速运输系统经轴突进行逆行运输。
Virology. 1998 Oct 10;250(1):67-75. doi: 10.1006/viro.1998.9360.
4
The pathogenesis of poliomyelitis: what we don't know.脊髓灰质炎的发病机制:我们所未知的内容。
Adv Virus Res. 2008;71:1-50. doi: 10.1016/S0065-3527(08)00001-8.
5
Multiple pathways for establishment of poliovirus infection.脊髓灰质炎病毒感染建立的多种途径。
Virus Res. 1999 Aug;62(2):97-105. doi: 10.1016/s0168-1702(99)00040-4.
6
One hundred years of poliovirus pathogenesis.脊髓灰质炎病毒发病机制的百年历程。
Virology. 2006 Jan 5;344(1):9-16. doi: 10.1016/j.virol.2005.09.015.
7
Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.脊髓灰质炎转基因小鼠模型中脊髓灰质炎病毒的减毒与发病机制
Dev Biol Stand. 1993;78:109-16.
8
Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.使用对脊髓灰质炎病毒敏感的转基因小鼠对口服脊髓灰质炎减毒活疫苗进行神经毒力试验。
Virology. 1995 Feb 1;206(2):1075-83. doi: 10.1006/viro.1995.1030.
9
A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.通过在携带人脊髓灰质炎病毒受体的转基因小鼠TgPVR21中进行黏膜感染建立的脊髓灰质炎模型。
Virology. 2004 Mar 30;321(1):87-100. doi: 10.1016/j.virol.2003.12.008.
10
Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.重组溶瘤脊髓灰质炎病毒/人鼻病毒在脊髓灰质炎病毒受体转基因小鼠中的生长表型和生物安全性概况
J Med Virol. 2008 Feb;80(2):352-9. doi: 10.1002/jmv.21063.

引用本文的文献

1
CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.中枢神经系统病毒感染——改善药物治疗需要考虑的因素:呼吁采用数学建模方法。
CNS Drugs. 2024 May;38(5):349-373. doi: 10.1007/s40263-024-01082-3. Epub 2024 Apr 5.
2
Enterovirus and Encephalitis.肠道病毒与脑炎
Front Microbiol. 2020 Feb 20;11:261. doi: 10.3389/fmicb.2020.00261. eCollection 2020.
3
Molecular mechanism of poliovirus Sabin vaccine strain attenuation.脊髓灰质炎病毒沙宾疫苗株减毒的分子机制。
J Biol Chem. 2018 Oct 5;293(40):15471-15482. doi: 10.1074/jbc.RA118.004913. Epub 2018 Aug 20.
4
The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.嗅球:嗜神经性病毒感染期间的免疫感觉效应器官。
ACS Chem Neurosci. 2016 Apr 20;7(4):464-9. doi: 10.1021/acschemneuro.6b00043. Epub 2016 Apr 8.
5
An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.从疫苗衍生脊髓灰质炎病毒神经毒力的角度洞察与肠道病毒C种的重组及核苷酸G-480回复突变
Sci Rep. 2015 Nov 25;5:17291. doi: 10.1038/srep17291.
6
Translation initiation of viral mRNAs.病毒 mRNAs 的翻译起始。
Rev Med Virol. 2010 May;20(3):177-95. doi: 10.1002/rmv.649.
7
Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.HEK 293细胞中细胞类型特异性脊髓灰质炎病毒增殖的遗传决定因素。
J Virol. 2005 May;79(10):6281-90. doi: 10.1128/JVI.79.10.6281-6290.2005.
8
Poliovirus tropism and attenuation are determined after internal ribosome entry.脊髓灰质炎病毒的嗜性和减毒是在核糖体内部进入后确定的。
J Clin Invest. 2004 Jun;113(12):1743-53. doi: 10.1172/JCI21323.